| Valentine JF, Fedorak RN, Feagan B, et al. Steroid-sparing Properties of Sargramostim in Patients With Corticosteroid-dependent Crohn's disease: A Randomised, Double-blind, Placebo-controlled, Phase 2 Study. [JOURNAL ARTICLE] Gut 2009 Jun 7. Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Spitler LE, Weber RW, Allen RE, et al. Recombinant Human Granulocyte-macrophage Colony-stimulating Factor (GM-CSF, Sargramostim) Administered for 3 Years as Adjuvant Therapy of Stages II(T4), III, and IV Melanoma. [JOURNAL ARTICLE] J Immunother 2009 May 28. Abstract | Full Citation | | Takazoe M, Matsui T, Motoya S, et al. Sargramostim in patients with Crohn's disease: results of a phase 1-2 study. [JOURNAL ARTICLE] J Gastroenterol 2009 Apr 8. Abstract | Full Citation | | Lutzky J, Weber R, Nunez Y, et al. A phase 1 study of granulocyte macrophage colony-stimulating factor (sargramostim) and escalating doses of thalidomide in patients with high-risk malignant melanoma. [Journal Article, Research Support, Non-U.S. Gov't] J Immunother 2009 Jan; 32(1):79-85. Abstract | Full Citation | | Crawford J, Armitage J, Balducci L, et al. Myeloid growth factors. [Journal Article] J Natl Compr Canc Netw 2009 Jan; 7(1):64-83. Full Citation | Find Related Articles | | Markovic SN, Suman VJ, Nevala WK, et al. A Dose-Escalation Study of Aerosolized Sargramostim in the Treatment of Metastatic Melanoma: An NCCTG Study. [JOURNAL ARTICLE] Am J Clin Oncol 2008 Dec; 31(6):573-579. Abstract | Full Citation | | Sato T, Eschelman DJ, Gonsalves CF, et al. Immunoembolization of Malignant Liver Tumors, Including Uveal Melanoma, Using Granulocyte-Macrophage Colony-Stimulating Factor. [JOURNAL ARTICLE] J Clin Oncol 2008 Oct 6. Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Waxman IM, Militano O, Baldinger L, et al. Sequential administration of sargramostim and filgrastim in pediatric allogeneic stem cell transplantation recipients undergoing myeloablative conditioning. [JOURNAL ARTICLE] Pediatr Transplant 2008 Sep 10. Abstract | Full Citation | Find Related Articles | | Huisman P, Grutters JC, van den Bosch JM [Pulmonary alveolar proteinosis: a disease caused by surfactant accumulation, and new treatment with sargramostim] [Case Reports, English Abstract, Journal Article] Ned Tijdschr Geneeskd 2008 Jun 28; 152(26):1450-4. Abstract | Full Citation | Find Related Articles | | Elias EG, Zapas JL, McCarron EC, et al. Sequential administration of GM-CSF (Sargramostim) and IL-2 +/- autologous vaccine as adjuvant therapy in cutaneous melanoma: an interim report of a phase II clinical trial. [Journal Article, Research Support, Non-U.S. Gov't] Cancer Biother Radiopharm 2008 Jun; 23(3):285-91. Abstract | Full Citation |  |
|
| | Advertise on this site.
|